← brief for 2026-08-18 · Slowing decline
Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design
Key takeaways
A paper on kidney trial design: using eGFR slopes and handling death as a competing risk. It discusses how to better measure kidney function decline.
Who did this work
Carmine Zoccali (Experimental Station for the Industry of the Essential Oils and Citrus Products) · Adeera Levin (University of British Columbia)
Source
Paper · OpenAlex, CKD works · 2026-08-16
https://doi.org/10.1093/ndt/gfag176